DRUG REGULATORY REFORMS IN INDIA

25th September 2015 (Friday), Juniper Hall, India Habitat Centre, New Delhi

 

 

1530 hours                         Registration & High Tea

 

INAUGURAL SESSION

 

1600 – 1605                     Welcome Remarks

Dr Shankar Acharya

Honorary Professor, ICRIER; Former Chief Economic Adviser, Government of India

 

1605 – 1620                     Inaugural Address

Dr G N Singh

Drugs Controller General of India, Central Drugs Standard Control Organization

(CDSCO), Ministry of Health and Family Welfare, Government of India

 

1620 – 1635                     Special Address

Dr Ranjit Roy Chaudhury

National Professor of Pharmacology, National Academy of Medical Sciences (NAMS); Former Advisor to Union Minister of Health and Family Welfare, Government of India

 

1635 – 1650                     Keynote Address

Dr Kathleen Holloway

Regional Advisor (Essential Drugs and Medicines), WHO SEARO

PRESENTATION & DISCUSSION SESSION

Chair: Dr Aditya Bhattacharjea, Professor and Head, Department of Economics, Delhi School of Economics

 

1650 – 1720                     Paper Presentation 1

“Administrative Structure and Functions of Drug Regulatory Authorities in India”

Dr Nupur Chowdhury, Consultant, ICRIER [Download Presentation]

 

1720 – 1750                     Paper Presentation 2

“Drug Quality and Safety Issues in India”

Mr Maulik Chokshi, Consultant, ICRIER [Download Presentation]

 

1750 – 1900                     Panel Discussion

Dr Hemant Koshia, Commissioner, Food and Drugs Control Administration, Gujarat

Shri Ravi Prakash Gupta, Controller, Food and Drugs Administration, Chhattisgarh

Ms Susan Winckler, Managing Partner, Leavitt Partners LLC, Washington, DC

Mr D G Shah, Secretary General, Indian Pharmaceutical Alliance

Mr Richard Kingham, Partner, Covington and Burling LLP, Washington, DC

 

1900 – 1930                     Q&A

 

1930 hours onwards      Cocktails & Dinner